concept

VASCULAR DYSFUNCTION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about VASCULAR DYSFUNCTION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

18Connections
0Hypotheses
3Analyses
6Outgoing
12Incoming
0Experiments
5Debates

No summary available yet. View on Wiki →

No AI portrait yet

💡 Concept Info
NameVASCULAR DYSFUNCTION

Pathway Diagram

graph TD
    VASCULAR_DYSFUNCTION[VASCULAR DYSFUNCTION]
    VASCULAR_DYSFUNCTION -->|contributes to| Alzheimer_Disease[Alzheimer Disease]
    VASCULAR_DYSFUNCTION -->|contributes to| ALZHEIMER_S_DISEASE[ALZHEIMER'S DISEASE]
    VASCULAR_DYSFUNCTION -->|contributes to| Alzheimer_s_Disease[Alzheimer's Disease]
    VASCULAR_DYSFUNCTION -->|causes| dementia[dementia]
    Endothelial_Cell_Senescence[Endothelial Cell Senescence] -->|contributes to| VASCULAR_DYSFUNCTION
    Senescent_Endothelial_Cells[Senescent Endothelial Cells] -->|contributes to| VASCULAR_DYSFUNCTION
    Cns_Macrophages[Cns Macrophages] -.protects against.-> VASCULAR_DYSFUNCTION
    IL6[IL6] -->|promotes| VASCULAR_DYSFUNCTION
    Perivascular_Macrophages[Perivascular Macrophages] -.protects against.-> VASCULAR_DYSFUNCTION
    Complement_Activation[Complement Activation] -->|contributes to| VASCULAR_DYSFUNCTION
    endothelial_cell_senescence[endothelial cell senescence] -->|causes| VASCULAR_DYSFUNCTION
    MMP9[MMP9] -->|activates| VASCULAR_DYSFUNCTION
    CD2AP[CD2AP] -->|implicated in| VASCULAR_DYSFUNCTION

Outgoing (6)

TargetRelationTypeStr
Alzheimer Diseasecontributes_todisease0.85
ALZHEIMER'S DISEASEcontributes_todisease0.75
Alzheimer's Diseasecontributes_todisease0.75
neurodegenerationassociated_withdisease0.70
dementiacausesdisease0.70

Incoming (12)

SourceRelationTypeStr
Endothelial Cell Senescencecontributes_toprocess0.95
Cns Macrophagesprotects_againstcell_type0.85
IL6promotesprotein0.85
Senescent Endothelial Cellscontributes_tocell_type0.85
Perivascular Macrophagesprotects_againstcell_type0.82

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (3)

Scientific analyses that reference this entity

Survival Analysis of AD Patient Cohorts: Prognostic Markers and Time-to-Dementia

neurodegeneration | 2026-04-16 | 0 hypotheses

Multi-modal Biomarker Panel Design for Early AD Detection

neurodegeneration | 2026-04-16 | 0 hypotheses

Why do clinical manifestations overlap despite distinct underlying etiologies in

neuroinflammation | 2026-04-08 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (5)

Multi-agent debates referencing this entity

Can a multi-modal biomarker panel combining plasma proteins, neuroimaging featur

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Which clinical, genetic, and biomarker features are independent prognostic marke

closed · Rounds: 4 · Score: 0.60 · 2026-04-21

Is a 3-marker prognostic index clinically actionable for MCI patients, or does t

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Should clinical practice adopt multi-modal biomarker panels now, or wait for sin

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

The abstract notes that clinical presentations overlap across different myelopat

closed · Rounds: 4 · Score: 0.86 · 2026-04-09